<?xml version="1.0" encoding="UTF-8"?>
<ref id="cam41388-bib-0012">
 <label>12</label>
 <mixed-citation publication-type="journal" id="cam41388-cit-0012">
  <string-name>
   <surname>Vogel</surname>, 
   <given-names>C. L.</given-names>
  </string-name>, 
  <string-name>
   <given-names>M. Z.</given-names>
   <surname>Wojtukiewicz</surname>
  </string-name>, 
  <string-name>
   <given-names>R. R.</given-names>
   <surname>Carroll</surname>
  </string-name>, 
  <string-name>
   <given-names>S. A.</given-names>
   <surname>Tjulandin</surname>
  </string-name>, 
  <string-name>
   <given-names>L. J.</given-names>
   <surname>Barajas‐Figueroa</surname>
  </string-name>, 
  <string-name>
   <given-names>B. L.</given-names>
   <surname>Wiens</surname>
  </string-name>, et al. 
  <year>2005</year>
  <article-title>First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double‐blind, placebo‐controlled phase III study</article-title>. 
  <source>J. Clin. Oncol.</source>
  <volume>23</volume>:
  <fpage>1178</fpage>–
  <lpage>1184</lpage>.
  <pub-id pub-id-type="pmid">15718314</pub-id>
 </mixed-citation>
</ref>
